Also known as: mRNA-based treatments
The US pharmaceutical drug delivery market is projected to rise from USD 0.94 billion in 2026 to USD 1.24 billion by 2031 at a 5.8% CAGR. Injectables, oncology applications, and home care settings are expected to post the fastest growth.
New market reports forecast significant expansion in CAR T-cell therapy, US pharmaceutical drug delivery, and healthcare nanotechnology sectors, driven by chronic disease prevalence and technological advances.
The National Security Commission on Emerging Biotechnology toured Pittsburgh's advanced research facilities, including Carnegie Mellon's AI Science Foundry and the University of Pittsburgh's BioForge building, as part of a nationwide biotechnology hub assessment.
